THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocol
Jameel Abdulrehman(University Health Network), Kevin H.M. Kuo(University Health Network), Stéphanie Forté(University Health Network), Pablo Bartolucci(UNESCO), Ziad Solh(Western University), Lauren Bolster(University of Alberta), George Tomlinson(Toronto General Hospital), Haowei Sun(University of Alberta)
Cited by 4
Related Papers
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
|The Lancet|2017|775
High Body Mass Index Is An Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C
|Hepatology|2003|359
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
|The Lancet Diabetes & Endocrinology|2020|228